HomeProductsBuilding BlocksFunctional GroupsKetonesMitoxantrone
Chemical structure of CAS 65271-80-9

Mitoxantrone

In Stock•Starting at $8 for 1 mg•Purity ≥ 97%
CAS No.65271-80-9
MDL No.MFCD00242942
MFC22H28N4O6
MW444.50
InChI KeyKKZJGLLVHKMTCM-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98%$8In Stock
25 mg97.0%$25In Stock
50 mg98%$42In Stock
100 mg97.0%$47In Stock
250 mg98%$82In Stock
1 g98%$270In Stock
5 g98%$1204In Stock
10 g98%$1923In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Mitoxantrone is a dihydroxyanthraquinone, specifically 1,4-dihydroxy-9,10-anthraquinone, substituted with 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8. It functions as an antineoplastic agent and an analgesic.

CAS No.65271-80-9
Product NameMitoxantrone

Biological Targets

TOP2A

Associated Conditions

neoplasm·diffuse large B-cell lymphoma·acute promyelocytic leukemia·hepatocellular carcinoma·Malignant Pancreatic Neoplasm·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Chemotherapy and marrow transplantation for congenital leukaemia.

Archives of disease in childhood. Fetal and neonatal edition • Vol. 84, Issue 1 • 2001
PMID: 11124925PMC: PMC1721195DOI: 10.1136/fn.84.1.f47

DNA-interactive anticancer aza-anthrapyrazoles: biophysical and biochemical studies relevant to the mechanism of action.

Molecular pharmacology • Vol. 59, Issue 1 • 2001
PMID: 11125029DOI: 10.1124/mol.59.1.96

The role of laparoscopy in second-look evaluations for ovarian cancer.

Gynecologic oncology • Vol. 80, Issue 1 • 2001
PMID: 11136568DOI: 10.1006/gyno.2000.6036

Serum LDH, a prognostic factor in elderly patients with acute myelogenous leukaemia.

British journal of cancer • Vol. 84, Issue 1 • 2001
PMID: 11139330PMC: PMC2363624DOI: 10.1054/bjoc.2000.1537

Documentation

Similar Products